Show simple item record

Authordc.contributor.authorYáñez Osses, Osvaldo Andrés
Authordc.contributor.authorOsorio, Manuel Isaías
Authordc.contributor.authorAreche Medina, Carlos Alberto
Authordc.contributor.authorVásquez Espinal, Alejandro
Authordc.contributor.authorBravo, Jéssica
Authordc.contributor.authorSandoval Aldana, Angélica
Authordc.contributor.authorPérez Donoso, José M.
Authordc.contributor.authorGonzález Nilo, Fernando Danilo
Authordc.contributor.authorMatos, María Joao
Authordc.contributor.authorOsorio, Edison
Authordc.contributor.authorGarcía Beltrán, Olimpo José
Authordc.contributor.authorTiznado Vásquez, William Artemio
Admission datedc.date.accessioned2022-03-04T18:29:25Z
Available datedc.date.available2022-03-04T18:29:25Z
Publication datedc.date.issued2021
Cita de ítemdc.identifier.citationBiomedicine & Pharmacotherapy 140 (2021) 111764es_ES
Identifierdc.identifier.other10.1016/j.biopha.2021.111764
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/184060
Abstractdc.description.abstractCocoa beans contain antioxidant molecules with the potential to inhibit type 2 coronavirus (SARS-CoV-2), which causes a severe acute respiratory syndrome (COVID-19). In particular, protease. Therefore, using in silico tests, 30 molecules obtained from cocoa were evaluated. Using molecular docking and quantum mechanics calculations, the chemical properties and binding efficiency of each ligand was evaluated, which allowed the selection of 5 compounds of this series. The ability of amentoflavone, isorhoifolin, nicotiflorin, naringin and rutin to bind to the main viral protease was studied by means of free energy calculations and structural analysis performed from molecular dynamics simulations of the enzyme/inhibitor complex. Isorhoifolin and rutin stand out, presenting a more negative binding Delta G than the reference inhibitor N-[(5-methylisoxazol-3-yl)carbonyl]alanyl-L-valylN-1--((1R,2Z)- 4-(benzyloxy)- 4-oxo-1-{[(3R)- 2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide (N3). These results are consistent with high affinities of these molecules for the major SARS-CoV-2. The results presented in this paper are a solid starting point for future in vitro and in vivo experiments aiming to validate these molecules and /or test similar substances as inhibitors of SARS-CoV-2 protease.es_ES
Patrocinadordc.description.sponsorshipMinistry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia Ministry of Education Ministry of Industry, Commerce and Tourism Francisco Jose de Caldas Fund RC-FP44842-212-2018 FONTAGRO ATN-RF 16109 RG Portuguese Foundation for Science and Technology CEECIND/02423/2018 UIDB/00081/2020 National Agency for Research and Development ECOS170045 Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDECYT 1211128 ANID/PIA (Chile) ACT192144es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherElsevieres_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceBiomedicine & Pharmacotherapyes_ES
Keywordsdc.subjectTheobroma cacaoes_ES
Keywordsdc.subjectAntioxidantes_ES
Keywordsdc.subjectBioflavonoidses_ES
Keywordsdc.subjectSARS-CoV-2es_ES
Keywordsdc.subjectMolecular dynamicses_ES
Keywordsdc.subjectDFTes_ES
Títulodc.titleTheobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 proteasees_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorcfres_ES
Indexationuchile.indexArtículo de publícación WoSes_ES
Indexationuchile.indexArtículo de publicación SCOPUSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States